ClinicalTrials.gg
Sign In

Hypertrophy, Left Ventricular clinical trials

The registry lists 162 studies for Hypertrophy, Left Ventricular across more than 10 countries. 28 are recruiting or about to start. 49 of them are mainly about Hypertrophy, Left Ventricular (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-27.

Get an email when these change. Save the Hypertrophy, Left Ventricular studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
93
Status unknown
25
Recruiting
20
Terminated
9
Not yet recruiting
7
Active, not recruiting
3

Phase

Phase 4
38
Phase 3
18
Phase 2
18
Early Phase 1
1

Where

United States
38
United Kingdom
16
France
14
Germany
14
Italy
13
China
11

Who runs them

National Heart, Lung, and Blood Institute (NHLBI) (5) · Novartis Pharmaceuticals (4) · Massachusetts General Hospital (4) · University of Dundee (4) · Medical University of Vienna (3) · Washington University School of Medicine (3) · Unity Health Toronto (3) · University of Aarhus (3)

What is being tested here

Drugs under test in Hypertrophy, Left Ventricular studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Eplerenone104
Colchicine102
Chlorthalidone101
Potassium101
Valsartan027
Tadalafil004
Everolimus003
Allopurinol003
Amlodipine013
Paricalcitol023

Drug classes tested here Angiotensin receptor blockers (ARBs) 1 open · Mineralocorticoid receptor antagonists (MRAs) 1 open · Diuretics 1 open · Calcium channel blockers 5 · SGLT2 inhibitors 4

Coming up

0phase 3 studies under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 20 Hypertrophy, Left Ventricular studies recruiting now, 13 (65%) set no upper age limit and 2 (10%) stop at 75 or younger. 4 (20%) take children under 18. 0 (0%) are for women only and 1 (5%) for men only; 7 (35%) take healthy volunteers.

Recruiting studies that take each age, of 20
AgeWomenMen
103 (15%)4 (20%)
1814 (70%)15 (75%)
3014 (70%)15 (75%)
4017 (85%)18 (90%)
5017 (85%)18 (90%)
6518 (90%)19 (95%)
7518 (90%)19 (95%)
8516 (80%)17 (85%)

Across all 162 studies, recruiting or not: 25% stop at 75 or younger and 13% at 65; 14% take children; 1% are for women only and 2% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hypertrophy, Left Ventricular studies take

Of 14 phase 4 interventional studies under Hypertrophy, Left Ventricular, half reached primary completion within 30 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 430 mo25–44 · 14 studies——
Observational38 mo32–58 · 18 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 162. Browse all 162 → or search them.